Diem Nguyen - 31 Dec 2021 Form 5/A - Amendment Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ John Canepa, Attorney-in-Fact
Issuer symbol
CADL
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5/A - Amendment
Filing time
14 Feb 2022, 19:31:38 UTC
Date Of Original Report
14 Feb 2022
Previous filing
02 Aug 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +28,480 $0.000000 28,480 26 Jul 2021 Common Stock 28,480 $8.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

This Form 5/A is being filed to correct the number of shares underlying options reported in Table II, Columns 5, 7 and 9.